A year after receiving FDA clearance for their smartphone-connected glucometer, Israel-based DarioHealth is in good shape, reporting record revenues, an increasing user base and big plans to expand with payers, new markets and partnerships to monetize big data.

On an earnings call, DarioHealth CEO Erez Raphael told investors the fourth quarter of 2016 “seriously advanced” the company in the United States. After receiving the CE Mark in 2013 for the DarioHealth system – which consists of a pocket-sized device that includes a glucose meter, disposable test strip cartridge, a lancing device and a companion smartphone app – the company moved onto Canada in 2015 and then the United States in 2016, and is now eyeing a global presence.

Read more on MobiHealthNews here.